Login / Signup

A randomized, blinded, controlled trial to assess sand fly mortality of fluralaner administered orally in dogs.

Sonia Ares GomezJavier LucientesJuan Antonio CastilloMaria Paz PerisSarah DelacourPaula OrtegaRonald-Vladimir OropezaAlbert Picado
Published in: Parasites & vectors (2018)
Control sand fly mortality 24 h after feeding was always ≤ 20% and mortality in the fluralaner group ranged from 2% (95% CI: 0-4%) 7 days before treatment to 100% at 3 days post-treatment. Fluralaner efficacy was 100, 93, 94 and 75% at Days 3, 17, 31 and 45, respectively (P < 0.0001). The increase in the risk of sand fly death was 32.9 (95% CI: 4-263), 76 (95% CI: 8-705), 95.8 (95% CI: 9-1029) and 10.6 times (95% CI: 1.43-79) on Days 3, 17, 31 and 45, respectively CONCLUSIONS: The efficacy of fluralaner, orally administered to dogs, against sand-flies was above 90% for 31 days. Fluralaner administered to dogs should be further evaluated as a control strategy in ZVL endemic areas.
Keyphrases
  • drinking water
  • cardiovascular events
  • risk factors
  • drosophila melanogaster
  • type diabetes
  • cardiovascular disease
  • randomized controlled trial
  • combination therapy
  • clinical trial
  • double blind